Previous close | 195.20 |
Open | 196.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 196.00 - 196.00 |
52-week range | 152.30 - 231.43 |
Volume | |
Avg. volume | 1,997 |
Market cap | 284.094M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 0.77 |
EPS (TTM) | 2.54 |
Earnings date | 29 Aug 2023 - 04 Sept 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Veeva Systems (NYSE: VEEV) is a cloud-based software provider to pharmaceutical companies and other members of the highly regulated life-science industry. Generally, biotechnology start-ups use Veeva Vault applications to keep track of data collected from laboratory research and clinical trials. Companies with approved drugs to sell tend to bundle Vault with Veeva's customer relationship management (CRM) products.
The fact that multiple Veeva Systems Inc. ( NYSE:VEEV ) insiders offloaded a considerable amount of shares over the...
Veeva Systems' (NYSE: VEEV) stock price surged 20% on June 1 after the cloud-based software company posted its latest earnings report. For the first quarter of fiscal 2024, which ended on April 30, its revenue rose 4% year over year to $526 million and exceeded analysts' estimates by $9 million.
The stock is trading at a high multiple despite revenue that's growing by mid-single-digit percentages.
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both segments.
Shares of Veeva Systems (NYSE: VEEV) are making big gains in Thursday's daily trading session following better-than-expected earnings results. The healthcare software company's share price was up roughly 15% as of 10:30 a.m. ET, according to data from S&P Global Market Intelligence. The company recorded a profit of $0.91 per share on revenue of $526.3 million and beat the average analyst estimate's call for per-share earnings of $0.79 on sales of $515.86 million.
Good afternoon and welcome to Veeva's fiscal 2024 first-quarter earnings conference call for the quarter ended April 30th, 2023. As a reminder, we posted prepared remarks on Veeva's Investor Relations website just after 1 p.m. Pacific today. Today's call will be used primarily for Q&A. With me today for Q&A are Peter Gassner, our chief executive officer; Paul Shawah, EVP, commercial strategy; and Brent Bowman, our chief financial officer.
While the top- and bottom-line numbers for Veeva (VEEV) give a sense of how the business performed in the quarter ended April 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Veeva (VEEV) delivered earnings and revenue surprises of 15.19% and 2.11%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) expands its partnership with Lotus Clinical to accelerate clinical trials.
Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.
Veeva Systems' (VEEV) new offering is expected to facilitate effective engagement with customers and KOLs for improved patient journeys.
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
Toast (TOST) delivered earnings and revenue surprises of 11.11% and 8.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Following its seizure by the FDIC and subsequent sale of its assets to JPMorgan Chase, First Republic Bank was replaced by Axon Enterprise in the S&P 500 index. Comprising 500 of the biggest and best U.S. stocks, the historic index has already made five additions in 2023, leaving investors to wonder what qualifying stocks could join the S&P 500 next. Three businesses that may fit the bill are The Trade Desk (NASDAQ: TTD), Veeva Systems (NYSE: VEEV), and Airbnb (NASDAQ: ABNB) because each dominates their respective niches and meets the requirements.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Veeva Systems (NYSE: VEEV) and Etsy (NASDAQ: ETSY) are two such examples. The company's fiscal 2023 ended on Jan. 31. Veeva's adjusted earnings came in at $4.28 per share, up 14.7% compared to the previous fiscal year.
Adobe (NASDAQ: ADBE) is an established tech leader with sustainable competitive advantages, above-average growth, and strong cash flows. The company is known for its suite of productivity and design software, which has become an essential tool for people in creative positions. Analysts expect Adobe to grow nearly 15% annually over the medium term, which should outpace most stocks.
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Shares of Veeva Systems (NYSE: VEEV) rose 10.9% last month following a strong quarterly earnings report. The stock enjoyed momentum in the second half of March as tech stocks charged higher, spurred on by hopes that macroeconomic conditions would become more favorable for growth stocks this year. Veeva reported earnings on March 1, and investors were pleased.